Skip to main content
Premium Trial:

Request an Annual Quote

Researchers Complete Sequencing Unique Agrobacterium

NEW YORK, Aug. 22 – Researchers at the University of Washington School of Medicine earlier this week announced that they have finished sequencing and annotating  Agrobacterium tumefaciens , a bacterium with a unique ability to insert genetic material into other organisms.

The project, partially funded by a National Science Foundation grant, also includes investigators from DuPont and the University of Campinas in Brazil.

While much is already understood about the DNA-transfer mechanism of the C58 strain sequenced, relatively little is known about the role of non-plasmid genes scattered throughout the bacterium’s approximately 5.67 million base pairs, according to University of Washington investigators. The sequencing project strives to identify the genes and uncover their function by comparing it to other bacterial genes whose function is already known.

Project investigators plan to use the information to better understand interactions between bacteria and plant and animal host cells. Predicted applications of that knowledge include genetic engineering of foodstuffs to produce crops with increased resistance to temperature extremes, high salt concentration, and attack by disease and insects, according to University of Washington researchers.

The investigators note that analysis of the A. tumefaciens genome is particularly significant as it is an extremely large genome compared with other sequenced bacteria, and that it lives in many different environments whereby many earlier sequenced bacteria live only in highly specialized biomes.

Investigators have said that the sequence and annotation information will be freely available on the Internet.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.